NOVO — April 2022
-
Bernstein: Ændrer kursmål for tre store danske medicinalvirksomheder https://proinvestor.com/investornyt/811262/bernstein-aendrer-kursmal-for-tre-store-danske-medicinalvirksomheder
-
Aktier/tendens: Kursmålsændringer til Mærsk, Novo og Carlsberg https://proinvestor.com/investornyt/811268/aktier-tendens-kursmalsaendringer-til-maersk-novo-og-carlsberg
-
Novo/Cowen: Anbefalingen og kursmål sendes i vejret https://proinvestor.com/investornyt/812835/novo-cowen-anbefalingen-og-kursmal-sendes-i-vejret
-
Novo Nordisk Get's CDSCO Nod to conduct Phase IIIa clinical trial of Anti-Neoplastic Concizumab
New Delhi: In line with the drug major Novo-Nordisk's proposal for Phase IIIa clinical trial of antineoplastic drug Concizumab, the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
(medicaldialogues.in)
-
højere omkostninger mener en analytiker: https://borsen.dk/nyheder/virksomheder/analysehus-inflation-koster-milliarder-for-novo-nordisk?utm_source=borsen&utm_medium=row_1&utm_campaign=news_1
-
Novo-rival viser lovende data med Wegovy-konkurrent
https://www.proinvestor.com/investornyt/815223/novo-rival-viser-lovende-data-med-wegovy-konkurrent -
Novo: Fase 3-data fra ugentligt insulin har nået endemål https://www.proinvestor.com/investornyt/815503/novo-fase-3-data-fra-ugentligt-insulin-har-naet-endemal-ny
-
-
Aktier/åbning: Novo brager op efter fremragende kvartal og opjustering https://proinvestor.com/investornyt/816018/aktier-abning-novo-brager-op-efter-fremragende-kvartal-og-opjustering
-
Fremragende firma...:-)
-
En lille historie fra det nordjyske. Novo skulle bruge 40 medarbejdere i 1 år til 3 holdskift på fabrikken i Hjørring. Der kom 445 ansøgninger.
-
Novo Q1: Vækst og opjustering drevet af Ozempic - NY https://www.proinvestor.com/investornyt/816026/novo-q1-vaekst-og-opjustering-drevet-af-ozempic-ny
-
Novo Q1: GLP-1-analoger trækker klart positiv overraskelse https://www.proinvestor.com/investornyt/816025/novo-q1-glp-1-analoger-traekker-klart-positiv-overraskelse-ny3
-
Novo/Sydbank: Stærkt momentum sikrer rendyrket opjustering https://www.proinvestor.com/investornyt/816023/novo-sydbank-staerkt-momentum-sikrer-rendyrket-opjustering
-
Vildt regnskab fra Novo:
https://www.proinvestor.com/boards/103162 -
Novo/CEO: Kolossal vækst i GLP-1 kunne potentielt være større - NY https://www.proinvestor.com/investornyt/816098/novo-ceo-kolossal-vaekst-i-glp-1-kunne-potentielt-vaere-storre-ny
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind